The Rainwater Charitable Foundation

Supporting scientific progress to understand primary tauopathies in neurodegenerative disease research.
Visit our website to discover all our funding programs.

[The Rainwater Charitable Foundation @RCFNeuro]

#Tau2026 highlighted growing momentum in tau research, with advancements in biomarkers, therapeutics, and disease biology shaping the path forward.

🔗 Explore how these developments are shaping the next phase of tau research: https://t.co/YR2KlPNG6m

[The Rainwater Charitable Foundation @RCFNeuro]

Advances in tau biology are informing future therapeutic strategies.

In @DrugTargetRev, read more from 2026 Rainwater Prize winner Dr. @marcaurelbusche on how our evolving understanding of tau species is informing drug discovery.
🔗: https://t.co/jV3ntNzyf0

[The Rainwater Charitable Foundation @RCFNeuro]

The 2027 Tauopathy Challenge Workshop will focus on how biological factors can shape cellular vulnerability, resilience, and organelle crosstalk in tau-related disease.

Submit your proposal for consideration: https://t.co/2m9xeMywJ1

[The Rainwater Charitable Foundation @RCFNeuro]

🧠 Join @Being_Patient_ on May 22 for a live Brain Talks with Dr. Melissa Murray (@DrNeuroChic), a 2026 Rainwater Prize winner, on how brain bank research is advancing our understanding of tauopathies.

Watch the 30-minute conversation: https://t.co/8NqokbCfnf

[The Rainwater Charitable Foundation @RCFNeuro]

Know a scientist shaping the future of tau research?

Nominations are open for the 2027 Rainwater Prize, including:
🏆 Outstanding Innovation in Neurodegenerative Research
🏆 Innovative Early‑Career Scientist

Nominate by June 25: https://t.co/55YNBeohUR

[The Rainwater Charitable Foundation @RCFNeuro]

"As #Tau2026 comes to a close, the final panel looked ahead, exploring where the field could headed by 2030. The path forward is ambitious, but the collective momentum across the tau community continues to move the field closer to effective therapies.
🔗https://t.co/XZx7LTmYql

[The Rainwater Charitable Foundation @RCFNeuro]

Momentum continued on Day 2 at #Tau2026 around advancing tau research from discovery toward clinical impact. Sessions highlighted therapeutic strategies targeting tau biology, novel delivery approaches, systems pharmacology, and ongoing clinical programs.🔗https://t.co/XZx7LTmYql

[The Rainwater Charitable Foundation @RCFNeuro]

Congratulations to Dr. @marcaurelbusche, winner of the Rainwater Prize for Innovative Early‑Career Scientist, honored at #Tau2026 for uncovering an early role of tau in disrupting brain activity, pointing to new treatment paths. https://t.co/vinXpcOODN

[The Rainwater Charitable Foundation @RCFNeuro]

At #Tau2026, we honored Rainwater Prize winners Drs. Dennis Dickson (@dennis_w_d) & Melissa Murray (@DrNeuroChic) for their contributions in combining brain banking, pathology, and imaging to enhance insights into tauopathies. https://t.co/vinXpcOODN

[The Rainwater Charitable Foundation @RCFNeuro]

Day 1 at #Tau2026 highlighted advances in tau biology, genetics, neuropathology, and biomarkers. Day 2 looks ahead to translation—from drug development and clinical research to collaborative strategies driving progress toward new therapies. https://t.co/XZx7LTmYql

[The Rainwater Charitable Foundation @RCFNeuro]

We’re kicking off #Tau2026, uniting researchers, clinicians, and advocates to accelerate progress in tau‑related neurodegenerative disease. We’re proud to join @alzassociation and @CurePSP in driving open science and collaboration.
🔗 Learn more: https://t.co/ifUagKnDte

[The Rainwater Charitable Foundation @RCFNeuro]

Patient voices took center stage as the FDA and other drug development decision-makers heard directly from people living with PSP. Learn about their experiences shared during @CurePSP’s Externally-Led Patient-Focused Drug Development meeting. https://t.co/sdoJu2Z7Bv

[The Rainwater Charitable Foundation @RCFNeuro]

Only about 25% of people with PSP, CBD, and MSA receive an accurate diagnosis, per @CurePSP. We’re proud to support efforts advancing research and awareness for these rare neurodegenerative diseases.

➡️ https://t.co/UkNSn8eJ0j
#HopeInAction

[The Rainwater Charitable Foundation @RCFNeuro]

Dr. Timothy Miller, 2023 Rainwater Prize winner and Tau Consortium member, leads this @JAMANeuro article reporting long‑term Phase 3 and open‑label extension results in SOD1-ALS. Catch up on this example of bold, patient-focused science: https://t.co/MJGOUpEaJv

[The Rainwater Charitable Foundation @RCFNeuro]

Now accepting LOIs for funding up to $750,000. The Tau Pipeline Enabling Program, jointly funded by the @alzassociation, invites researchers advancing tau‑targeted drug discovery and translation to apply. https://t.co/G0uspt1SDq

[The Rainwater Charitable Foundation @RCFNeuro]

🎧 In this episode of The Brain Podcast, @GGKovacsBrain, a Tau Consortium investigator, highlights a potential immune-driven component of PSP and what it could mean for disease biology and future treatments. https://t.co/TGLOTpBN9s

[The Rainwater Charitable Foundation @RCFNeuro]

Progress in neurodegenerative disease is built over decades. Read @washumedicine’s article on Dr. David Holtzman (@holtzman4), 2021 Rainwater Prize winner and Tau Consortium member, to learn how his work continues to shape neurodegenerative research. 🔗https://t.co/wNoiNoWSr3

[The Rainwater Charitable Foundation @RCFNeuro]

📺 Watch “How Do Concussions Affect the Brain?” a documentary on the first in-human PET study using [18F]OXD-2314 to track tau aggregation, shedding light on neurodegenerative diseases.

We’re proud to have supported this research: https://t.co/PcFTMqbyPn

@ConcussionCTEfn

[The Rainwater Charitable Foundation @RCFNeuro]

At #ADPD2026, the spotlight shifted to tau biology, disease heterogeneity, and precision biotyping. The field showed real progress toward patient impact, from AI‑driven plasma proteomics to proof of tau lowering in PSP. Read our key takeaways: https://t.co/LdPN6TSFLz

[The Rainwater Charitable Foundation @RCFNeuro]

🎧 Listen to this episode of the Alzheimer’s Breakthrough podcast as 2026 Rainwater Prize winner Dr. Melissa Murray (@DrNeuroChic) explains how earlier detection and brain donation are advancing more targeted approaches to neurodegenerative disease. https://t.co/1RRcble2wX